Despite the company's incessant assertions to the contrary, it is clear the FDA does not want Heplisav. They have frustrated the company at every turn. The company said back in June that in a few weeks the protocol for the new trial would be set. It has been 3 months. Each month the company burns through more and more cash and still no word on the trial and the number of patients and the protocol. Per the company's statement you are looking at about 3 years before the trial once commenced would be completed. Their patents by this time will have only a few years left. Now they put out some release on their asthma drug which is so far away it is essentially meaningless. The question is when will they raise money again ... I think it goes sub 1 in the next week on capitulation selling as this story is just so old and tired.